JOB DESCRIPTION: At Abbott, we help people live healthier, fuller lives — physically, emotionally, and socially. As a global healthcare leader with more than 107,000 employees across 160+ countries, we develop breakthrough technologies and solutions that
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)